Patients with resected Merkel cell carcinoma living in Medicaid expansion states show better stage-specific survival than ...
How do tertiary lymphoid structures influence immunotherapy outcomes in Merkel cell carcinoma? Spatial proteomics reveals key ...
Much like how a shot of espresso might re-energize you to get through the day, cancer immunotherapies have been developed to re-energize anti-tumor immune responses to help clear cancerous cells. When ...
It's the cancer-fighting immune cells in a Merkel cell carcinoma patient's blood — not their tumor — that best predicts whether a certain type of immunotherapy will work, according to new work from ...
Please provide your email address to receive an email when new articles are posted on . Merkel cell carcinoma is often diagnosed after metastasis to other organs. However, new findings show those with ...
Merkel cell polyomavirus (MCPyV) and ambient ultraviolet radiation (UVR) exposure account for most Merkel cell carcinoma (MCC) cases in the United States. Researchers evaluated 38,020 MCC cases (38% ...
Please provide your email address to receive an email when new articles are posted on . Pyrvinium pamoate showed promise in reducing the size of Merkel cell carcinoma tumors. Researchers “excited” ...
First-line of penpulimab and chemotherapy for advanced non-melanoma cutaneous carcinoma: A single center, single arm, exploratory study. This is an ASCO Meeting Abstract from the 2024 ASCO Annual ...
ctDNA testing effectively stratifies Merkel cell carcinoma patients into high and low recurrence risk categories, influencing surveillance strategies. The study's cohorts revealed significant ...
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today commented on recent updates by the NCCN on circulating tumor DNA (ctDNA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results